8-KItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
Johnson & Johnson Reaches Proposed $5.5 Billion Ovarian Talc Settlement
Filed with the SEC on · Summarized by InvestorsBot
Johnson & Johnson agreed to a proposed resolution of about 76,000 remaining ovarian talc claims, subject to participation by plaintiff firms representing at least 95% of the claims. The company will commit $5.5 billion in per-claim payments, with up to $3 billion due in 2027 and no additional payments before 2028; the agreement follows a July 22, 2026, court ruling on plaintiffs’ ability to prove specific causation.